SOX9 is a dose-dependent metastatic fate determinant in melanoma

Xintao Yang, Rui Liang, Chunxi Liu, Jessica Aijia Liu, May Pui Lai Cheung, Xuelai Liu, On Ying Man, Xin Yuan Guan, Hong Lok LUNG*, Martin Cheung

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)

Fingerprint

Dive into the research topics of 'SOX9 is a dose-dependent metastatic fate determinant in melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences